Zusammenfassung
Ziel: Bewertung von Acoustic Radiation Force Impulse Imaging (ARFI) von Leber und Milz als neue Methode für die nicht-invasive Bewertung der Leberfibrose (LF). Material und Methoden: Drei Gruppen mit insgesamt 58 Teilnehmern wurden untersucht: (A) 20 gesunde Probanden; (B) 18 Patienten mit chronisch viraler Hepatitis (CVH) B oder C mit Leberfibrose im Stadium F1-4 (beurteilt mittels Leberbiopsie, Ishak Klassifikation); und (C) 20 Patienten mit Leberzirrhose (LC). Alle Teilnehmer wurden mit dem Siemens ACUSON S2000 Ultrasound Virtual Touch Tissue QuantificationTM System untersucht. Zehn Messungen wurden an beiden Leberlappen und drei weitere an der Milz vorgenommen. Die gemessenen Mittelwerte der Transversalwellen Geschwindigkeiten (shear wave velocities (SWV), in m/s) wurden zwischen den Gruppen verglichen. Bei 20 Patienten wurde zudem der Pulsatilitätsindex der Arteria lienalis (SAPI) gemessen und mit dem Leber und Milz ARFI und dem histologischen Stadium der LF korreliert. Ergebnisse: Hepatische ARFI Messungen zeigten eine signifikante Korrelation mit den LB Ergebnissen (Spearman’s ρ = 0.766; p < 0,001) und die SWV Grenzwerte von 1,3 (AUC 0,96) und 1,86 (AUC 0,99) erlaubten eine sichere Unterscheidung von gesunder Leber (A), nicht-zirrhotischer CVH (B) und von LC (C). Für die Milz war der SWV Grenzwert von 2,73 (AUC 0,82) geeignet zur Differenzierung von Patienten mit LC und nicht-zirrhotischer CVH. Zwischen SAPI und den hepatischen ARFI Werten bestand eine signifikante Korrelation (ρ = 0,56; p = 0,013). Schlussfolgerung: Die mit ARFI gemessenen hepatischen und lienalen SWV steigen mit dem Stadium der LF und die hepatische SWV korreliert gut mit SAPI. Diese neue Technologie ermöglicht simultane morphologische, Doppler- und elastometrische Untersuchungen und scheint geeignet, die Genauigkeit der nicht-invasiven Fibrose Beurteilung zu verbessern.
Abstract
Purpose: To evaluate acoustic radiation force impulse imaging (ARFI) of the liver and spleen as a new method for the noninvasive assessment of liver fibrosis (LF). Materials and Methods: Three groups of 58 examinees were studied: (A) 20 healthy volunteers; (B) 18 patients with chronic viral hepatitis (CVH) B or C having liver fibrosis stages F 1 – 4 (assessed by liver biopsy; Ishak classification); and (C) 20 patients with liver cirrhosis (LC). All participants were examined using the Siemens ACUSON S 2000 Ultrasound Virtual Touch Tissue Quantification™ system. Ten measurements were performed on both liver lobes and three measurements on the spleen, and the obtained mean values (shear wave velocities [SWV] expressed in m/s) were compared between the groups. In 20 patients the splenic artery pulsatility index (SAPI) was also measured and correlated to the liver and splenic ARFI and histological stage of LF. Results: Hepatic ARFI measurements demonstrated a significant correlation to LB results (Spearman’s ρ = 0.766; ρ < 0.001) and SWV cut-off values of 1.3 (AUC 0.96) and 1.86 (AUC 0.99) could reliably differentiate between healthy (A) and non-cirrhotic CVH (B), as well as between non-cirrhotic CVH (B) and LC (C). Splenic SWV cut-off value of 2.73 (AUC 0.82) could differentiate between the patients with LC and non-cirrhotic CVH. A significant correlation was also observed between the SAPI and liver ARFI results (ρ = 0.56; p = 0.013). Conclusion: The hepatic and splenic SWV measured by ARFI increase with the LF stage, and the hepatic SWV correlate well with SAPI. This new technology enables simultaneous morphological, Doppler and elastometric examinations and might improve the accuracy of noninvasive liver fibrosis assessment.
Key words
abdomen - ultrasound color Doppler - infection - staging
References
1
Strassburg C P, Manns M P.
Approaches to Liver Biopsy Techniques-Revisited.
Semin Liver Dis.
2006;
26
318-327
2
Bravo A A, Sheth S G, Chopra S.
Liver Biopsy.
N Engl J Med.
2001;
344
495-500
3
Guha I N, Rosenberg W M.
Noninvasive Assessment of Liver Fibrosis: Serum Markers, Imaging, and Other Modalities.
Clin Liver Dis.
2008;
12
883-900
4
Gaiani S, Gramantieri L, Venturoli N et al.
What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy.
J Hepatol.
1997;
27
979-985
5
Aguirre D A, Behling C A, Alpert E et al.
Liver Fibrosis: Noninvasive diagnosis with double contrast material-enchanced MRI imaging.
Radiology.
2006;
239
425-437
6
Stauber R E, Lackner C.
Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C.
World J Gastroenterol.
2007;
13
4287-4294
7
Goodman Z D.
Grading and staging systems for inflammation and fibrosis in chronic liver diseases.
J Hepatol.
2007;
47
598-607
8
Bedossa P, Carrat F.
Liver biopsy: The best, not the gold standard.
J Hepatol.
2009;
50
1-3
9
Castera L, Forns X, Alberti A.
Non-invasive evaluation of liver fibrosis using transient elastography.
J Hepatol.
2008;
48
835-847
10
Sandrin L, Fourquet B, Hasquenoph J M et al.
Transient elastography: a new non-invasive method for assessment of hepatic fibrosis.
Ultrasound Med biol.
2003;
29
1705-1713
11
Degos F, Perez P, Roche B et al.
Performances of Fibroscan for diagnosis of significant fibrosis and cirrhosis. A prospective study of 1993 patients with chronic viral hepatitis.
J Hepatol.
2009;
50 (Suppl 1)
A96
12
De Ledinghen V, Fournier C, Foucher J et al.
New FibroScan probe for obese patients. A pilot study of feasibility and performances in patients with BMI≥kg/m2.
J Hepatol.
2009;
50 (Suppl 1)
A989
13 Nightingale K R, Zhai L, Dahl J J et al. Shear wave velocity estimation using acoustic radiation force impulsive excitation in liver in vivo. Proceedings of Institute of Electrical and Electronics Engineers Ultrasonics Symposium 2006. Institute of Electrical and Electronics Engineers. Vancouver, British Columbia, Canada; 2006: 1156-1160
14
Friedrich-Rust M, Wunder K, Kriener S et al.
Liver Fibrosis in Viral Hepatitis: Noninvasive Assesment with Acoustic Radiation Force Impulse Imaging versus Transient Elastography.
Radiology.
2009;
252
595-604
15
Lupsor M, Badea R, Stefanescu H et al.
Performance of a New Elastographic Method (ARFI Technology Compared to Unidimensional Transient Elastography int he Noninvasive Assessment of Chronic Hepatitis C. Preliminary Results.
J Gastrointestin Liver Dis.
2009;
18
303-310
16
Takahashi H, Ono N, Eguchi Y et al.
Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study.
Liver Int.
2009;
[Epub ahead of print]
17
Fierbrinteanu-Braticevici C, Andronescu D, Usvalt R et al.
Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis.
World J Gastroenterol.
2009;
15
5525-5532
18
Nishiura T, Watanabe H, Ito M et al.
Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes.
Br J Radiol.
2005;
78
189-197
19
Ishak K, Baptista A, Bianchi L et al.
Histological grading and staging of chronic hepatitis.
J Hepatol.
1995;
22
696-69
20
Abdalla E K, Denys A, Chevalier P et al.
Total and segmental liver volume variations: Implications for liver surgery.
Surgery.
2004;
135
404-410
21
Zhou X P, Lu T, Wei Y G et al.
Liver volume variation in patients with virus-induced cirrhosis: findings on MDCT.
AJR.
2007;
189
W153-W159
22
Bolognesi M, Sacerdoti D, Merkel C et al.
Noninvasive Grading of the Severity of Portal Hypertension in Cirrhotic Patients by Echo-color-Doppler.
Ultrasound in Med & Biol.
2001;
27
901-907
23
Huwart L, Sempoux C, Salameh N et al.
Liver fibrosis: Non invasive assessment with MR elastography versus aspartate aminotransferase-to- platelet ratio indeks.
Radiology.
2007;
245
458-466
24
Jugl V, Bernatik T, Handl T et al.
ARFI als Surrogatmarker einer Leberfibrosierung – Wo sollte gemessen werden?.
Ultraschall in Med.
2009;
30
S1
25
Rifai K, Bahr M J, Mederacke H et al.
Acoustic radiation force imaging as a new method of ultrasonographic elastography allows accurate and flexible assessment of liver stiffness.
J Hepatol.
2009;
50 (Suppl 1)
A217
26
Castera L, Vergniol J, Foucher J et al.
Prospective comparison of transient elastography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C.
Gastroenterology.
2005;
128
343-350
27
Di Marco V, Bronte F, Calvaruso V et al.
Fibrospleen: Measuring spleen stiffness by transient elastography increases accuracy of staging of liver fibrosis and of portal hypertension in chronic viral hepatitis.
J Hepatol.
2009;
50 (Suppl 1)
A391
28
Bolognesi M, Sacerdoti D, Merkel C et al.
Splenic Doppler Impedance Indices: Influence of Different Portal Hemodynamic Conditions.
Hepatology.
1996;
23
1035-1040
29
Talwalkar J A, Yin M, Venkatesh S et al.
Feasibility of In Vivo MR Elastographic Splenic Stiffness Measurements in the assessment of Portal Hypertension.
AJR.
2009;
193
122-127
30
Cholongitas E, Senzolo M, Standish R et al.
A Systematic Review of the Quality of Liver Biopsy Specimens.
Am J Clin Pathol.
2006;
125
710-721
Prof. Dr. Boris Brkljacic
Diagnostic and Interventional Radiology, University of Zagreb, University Hospital Dubrava, Zagreb
Avenija Gojka Suska 6
10 000 Zagreb
Phone: ++ 3 85/1/2 90 32 55
Fax: ++ 3 85/1/2 90 32 55
Email: boris.brkljacic@zg-t-com.hr